adam brufsky, md, phd, describes the treatment landscape of her2 metastatic breast cancer
Published 3 years ago • 132 plays • Length 2:39
Download video MP4
Download video MP3
Similar videos
-
3:21
adam brufsky, md, phd, considers the investigation of poziotinib in her2 metastatic breast cancer
-
2:00
adam brufsky, md, phd, discusses the issue of resistance to her2-targeted therapy
-
0:49
adam brufsky, md, phd: considerations for different therapies in breast cancer
-
4:05
an overview of immunotherapy in breast cancer - an interview with adam brufsky
-
1:44
adam brufsky, md, phd: choices of therapy in breast cancer
-
43:30
long lecture on methionine restriction to slow aging & help prevent cancer = fabian strategy
-
1:05:11
ask the expert: early-stage her2-positive breast cancer with adrienne waks, md
-
59:48
top 18 anti-estrogen foods that fight breast cancer | dr. kristi funk
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
59:39
er-positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
4:37
changing treatment landscape in metastatic breast cancer
-
1:10
adam brufsky, md, phd: choices of therapy
-
1:07
adam brufsky, md, phd: expectations of therapy in breast cancer
-
1:19
dr adam brufsky: choosing a therapy for breast cancer patients
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
1:06
dr. brufsky on challenges in breast cancer
-
1:23
dr. burstein on the treatment landscape of her2 breast cancer
-
1:04
adam brufsky, md, phd: expectations of therapy
-
1:38
dr. brufsky on the results of a study of trastuzumab and eribulin for her2 mbc
-
5:31
goals of therapy in metastatic breast cancer
-
2:12
dr adam brufsky discusses value coordinates of breast cancer care
Clip.africa.com - Privacy-policy